Evidence map›Paper›PMID 21055489›Full record

ArticleJournal of proteomics2011

Assigning statistical significance to proteotypic peptides via database searches.

Gelio Alves, Aleksey Y Ogurtsov, Yi-Kuo Yu

Open access · greenAbstract read
In one paragraph

Article in Journal of proteomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gelio AlvesNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Aleksey Y Ogurtsov
Yi-Kuo Yu
National Institutes of Health · USNational Center for Biotechnology Information · US

Funding

Robust Accurate Identification of peptides from tandem mass spectrometry dataZIALM092404 · NLM · NATIONAL LIBRARY OF MEDICINE · PI YU, YI-KUO · 2009 to 2025
$13.2M
Intramural NIH HHS ZIA LM092404
6 · The paper itself

Abstract

Querying MS/MS spectra against a database containing only proteotypic peptides reduces data analysis time due to reduction of database size. Despite the speed advantage, this search strategy is challenged by issues of statistical significance and coverage. The former requires separating systematically significant identifications from less confident identifications, while the latter arises when the underlying peptide is not present, due to single amino acid polymorphisms (SAPs) or post-translational modifications (PTMs), in the proteotypic peptide libraries searched. To address both issues simultaneously, we have extended RAId's knowledge database to include proteotypic information, utilized RAId's statistical strategy to assign statistical significance to proteotypic peptides, and modified RAId's programs to allow for consideration of proteotypic information during database searches. The extended database alleviates the coverage problem since all annotated modifications, even those that occurred within proteotypic peptides, may be considered. Taking into account the likelihoods of observation, the statistical strategy of RAId provides accurate E-value assignments regardless whether a candidate peptide is proteotypic or not. The advantage of including proteotypic information is evidenced by its superior retrieval performance when compared to regular database searches.

Indexed as

Databases, ProteinData Interpretation, StatisticalInformation Storage and RetrievalPeptidesProtein HydrolysatesProteomicsTrypsinPeptidesProtein HydrolysatesTrypsin

Identifiers

PMID21055489
PMCPMC3186061
OpenAlexW1978902428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.